Welcome to our dedicated page for DIGIPATH news (Ticker: DIGP), a resource for investors and traders seeking the latest updates and insights on DIGIPATH stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect DIGIPATH's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of DIGIPATH's position in the market.
Digipath, Inc. (OTCQB: DIGP) reported a remarkable 88% revenue increase in Q3 2021 compared to the same period last year, amounting to $764,015. The net loss decreased by 66% to $177,214, while gross margins improved to 28%, yielding a gross profit of $212,039. Management highlighted ongoing revenue gains, reducing operational losses by 69%. Adjustments in general and administrative expenses have strengthened the company's position amid the ongoing challenges posed by the pandemic, aligning with their strategy to evolve into a multi-state operator.
Digipath, Inc. (OTCQB: DIGP) has appointed Todd Denkin, a founder and former president, as its new president to lead the company's post-pandemic expansion. Despite challenges from the pandemic, Digipath has continued to innovate and execute its growth strategy. Denkin, who has extensive experience in the cannabis sector, aims to enhance the company's brand and take advantage of the national shortfall in cannabis testing capacity. He emphasizes the significant competitive edge Digipath holds in the cannabis testing market and its potential for growth.
On July 7, 2021, Digipath, Inc. (OTCQB: DIGP) announced the appointment of Stone Douglass as Vice Chairman of its Board of Directors. Douglass brings over 35 years of experience managing companies across various industries. He aims to leverage his expertise in corporate strategy and operations to strengthen Digipath’s position in the expanding cannabis testing market. Douglass emphasized that as legalization efforts grow, the demand for certified analytical testing labs, like Digipath, is increasing, positioning the company for significant growth.
Digipath, Inc. (OTCQB: DIGP) has announced a purchase agreement for a full suite of cannabis and hemp laboratory testing equipment, aiming to operate a new lab in California's Coachella Valley by the end of 2021. The company is positioned to become a multi-state operator, leveraging its experience in Nevada's regulated market. With California's stringent testing regulations and a significant demand for certified labs, the company seeks to address the shortage of testing facilities, as only 35 out of 100 required labs are currently operational in the state.
Digipath, Inc. (OTCQB: DIGP) reported its first profitable quarter, achieving net income of $18,201 for the second quarter of 2021, compared to a net loss of $609,143 in the same period last year. Revenue increased to $633,160, a 27% rise from the previous quarter’s $500,385. Gross margins improved remarkably to 34.2%, up from 15.9% in the previous quarter. The company has seen steady month-to-month revenue gains as Las Vegas tourism recovers from Covid-19 impacts, reflecting a positive trend in operational performance.